Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: DNA Damage and SETD2[original query] |
---|
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nature communications 2016 Oct 7 13131. Chen Ying-Bei, Xu Jianing, Skanderup Anders Jacobsen, Dong Yiyu, Brannon A Rose, Wang Lu, Won Helen H, Wang Patricia I, Nanjangud Gouri J, Jungbluth Achim A, Li Wei, Ojeda Virginia, Hakimi A Ari, Voss Martin H, Schultz Nikolaus, Motzer Robert J, Russo Paul, Cheng Emily H, Giancotti Filippo G, Lee William, Berger Michael F, Tickoo Satish K, Reuter Victor E, Hsieh James |
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling. Molecular genetics & genomic medicine 2019 Dec e1079. Chen Zhanhong, Sun Tian, Yang Ziyan, Zheng Yabing, Yu Ruoying, Wu Xue, Yan Junrong, Shao Yang W, Shao Xiying, Cao Wenming, Wang Xiaoj |
SETD2 loss and ATR inhibition synergize to promote cGAS signaling and immunotherapy response in renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 8 . Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail, Xuesong Zhang, Truong Lam, Anh Hoang, Elshad Hasanov, Ganiraju Manyam, Christine B Peterson, Haifeng Zhu, Shwetha V Kumar, Rehan Akbani, Patrick G Pilie, Nizar M Tannir, Guang Peng, Eric Jonas |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: